Therapeutic Handbook - GGC Prescribing

TeicoplaninDosing and monitoring................................................. 273TemocillinAlert Antibiotic Policy.................................................... 210TenecteplaseIn STEMI........................................................................ 96TerbutalineIn acute severe asthma................................................ 134TerlipressinIn decompensated liver disease with renal failure......... 59In variceal bleed............................................................. 61TetracyclineOral, in H. Pylori............................................................. 48TheophyllineReference range.......................................................... 345Therapeutic Drug Monitoring............................................ 344Thiamine, IV, IM, oralFor prophylaxis and treatment of Wernicke-KorsakoffEncephalopthy............................................................. 176ThrombolysisIn acute stroke.............................................................. 118In STEMI........................................................................ 95ThromboprophylaxisIn medical patients......................................................... 66TigecyclineAlert Antibiotic Policy.................................................... 210TobramycinDosing and monitoring................................................. 261Reference range.......................................................... 344TonsillitisTreatment of................................................................. 226Transient Ischaemic AttacksManagement of............................................................ 122Secondary prevention of.............................................. 124TrazodoneFor depression............................................................. 172TrichomoniasisTreatment of................................................................. 254TrimethoprimIn UTI (men)................................................................. 222In UTI (non-pregnant women)...................................... 219In UTI (pregnancy)............................................... 220, 221Tumour Lysis SyndromeManagement of............................................................ 334UUrinary tract infectionNon-gonococcal urethritis............................................ 252Treatment in men......................................... 222, 223, 224Treatment in non-pregnant women...................... 219, 220Treatment in pregnancy....................................... 220, 221Treatment of acute prostatitis....................................... 222Treatment of catheter-related infection........................ 225Treatment of cystitis (men)........................................... 222Treatment of epididymitis............................................. 223Treatment of orchitis.................................................... 223Treatment of sepsis (in pregnancy)...................... 220, 221VVaccinationsIn patients with absent / non-functioning spleen.......... 256Vaginosis, bacterialTreatment of................................................................. 253ValaciclovirIn varicella / herpes zoster........................................... 251Valproic acidReference range.......................................................... 345VancomycinDosing and monitoring of continuous infusion............. 270Dosing and monitoring of intermittent (pulsed)infusion......................................................................... 266In biliary tract infection................................................. 237In bone and joint infections.......................................... 245In C. difficile.................................................................. 239In cellulitis / erysipelas......................................... 241, 242In diabetic foot osteomyelitis........................................ 245In endocarditis (native heart valve).............................. 216In endocarditis (prosthetic heart valve)........................ 217In Listeria meningitis.................................................... 247In neutropenic sepsis................................................... 214In osteomyelitis............................................................ 245In peritonitis.................................................................. 236In pharyngitis (severe).................................................. 226In pneumonia (severe community acquired)................ 233In pneumonia (severe hospital acquired)..................... 234In pneumonia (staphylococcal infection)...................... 235In prosthetic joint infection............................................ 245In sepsis (community acquired)................................... 212In sepsis (healthcare associated)................................. 212In sepsis (proven S. aureus infection).......................... 213In sepsis (source unknown)......................................... 212In septic arthritis........................................................... 245In severe cellulitis / erysipelas...................................... 241In severe streptococcal infection.................................. 212Page 367